Indo Us Biotech Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting

#INDOUS Board Meeting Update: The company's board has approved the financial results for the quarter and half-year ended June 30, 2025. Key highlights include revenue of ₹30.79 Cr. The net profit for the quarter stood at ₹3.95 Cr, translating to Earnings Per Share (EPS) of ₹1.58. This financial snapshot offers retail investors a clear view of INDOUS's recent performance.